ARDX (Ardelyx Pharma) Rega marang bathi mangsa ngarep

Tandha merek ardelyx.com (ARDX)

Stable production of approved drugs in the US ensures the resilience of Ardelyx, Inc. (ARDX). The company's valuation based on forward P/E confirms this trend, with the metric standing at 16.30. Growth prospects are based on R&D in ion exchange and the expansion of hyperphosphatemia treatments, creating a powerful patent moat for long-term business development.

ARDX - Kapitalisasi marang proyeksi bathi ardelyx.com ing rentang 04.07.2022 - 14.11.2026

Ardelyx Corp (ARDX) - rincian metrik lan laporan keuangan

- rega saiki lan proyeksi nilai saham:
Kutipan saham Ardelyx|ARDX - Konsensus nilai wajar
- indikator valuasi pasar bisnis:
Nilai pasar Ardelyx Inc|ARDX - Nilai Perusahaan
- data ekuitas miturut neraca:
Nilai Buku saben Saham Ardelyx|ARDX - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku ardelyx.com|ARDX - Total Aset Bisnis
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas Ardelyx, Inc.|ARDX - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Ardelyx, Inc.|ARDX - Utang kumulatif perusahaan|Utang marang nilai buku Ardelyx Inc|ARDX - Utang jangka dawa|Utang jangka cendhak perusahaan Ardelyx|Likuiditas cepet ardelyx.com
- statistik bathi lan rasio pasar:
ARDX - Bathi pungkasan|Proyeksi bathi mangsa ngarep Ardelyx, Inc.|ARDX - Pangali rega marang bathi|Pangali Forward P/E Ardelyx Pharma|ARDX - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Ardelyx Inc|ARDX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Ardelyx|ARDX - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan ardelyx.com|ARDX - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Ardelyx, Inc.
- data pendapatan lan penerimaan dodolan:
ARDX - Pendapatan dodolan perusahaan|Prakiraan volume dodolan Ardelyx|ARDX - Koefisien rega marang pendapatan|Rasio rega marang prakiraan pendapatan Ardelyx Inc
Analisis kabeh metrik perusahaan:Ardelyx ARDX
Produk mawa merek Ardelyx Corp

Forward P/E determines the stock value relative to projected earnings for a future period. The ratio is calculated by dividing the current price by the expected annual net income. By analyzing the forward P/E for the coming year, an investor assesses the degree of optimism priced in. For Ardelyx, Inc. (ARDX), this metric is sensitive to Medicare reimbursement rates. Risks of secondary offerings and slow drug adoption could significantly adjust the final value of the multiple.

Pesaing Ardelyx, Inc. (ARDX)

Prakiraan rega marang bathi TVTX (Travere Therapeutics, Inc.)|PROK (ProKidney Corp) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Akebia AKBA|Pangali Forward P/E Cara Corp TVRD|DiaMedica Therapeutics - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi unicycive.com UNCY|RMTI: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep CVKD|Rega marang bathi mangsa ngarep Conduit Pharma|Rasio rega marang bathi mangsa ngarep CALT (Calliditas)|Pangali Forward P/E RNLX|ZVSA - Rasio prakiraan rega marang bathi